Cereno Scientific AB (publ) (STO:CRNO.B)
Sweden · Delayed Price · Currency is SEK 5.13
-0.09 (-1.72%)
At close: Jul 3, 2026
Cereno Scientific AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 67.1 | 44.27 | 80.9 | 49.28 | 57.54 | 44.81 |
Other Revenue | -0.28 | - | - | - | - | - |
| 66.82 | 44.27 | 80.9 | 49.28 | 57.54 | 44.81 | |
Revenue Growth (YoY) | -11.75% | -45.28% | 64.18% | -14.36% | 28.42% | 444.85% |
Gross Profit | 66.82 | 44.27 | 80.9 | 49.28 | 57.54 | 44.81 |
Selling, General & Admin | 144.53 | 117.74 | 154.5 | 89.9 | 84.12 | 59.57 |
Other Operating Expenses | 0.12 | - | - | 3.6 | - | - |
Operating Expenses | 145.43 | 118.53 | 154.78 | 93.51 | 84.13 | 59.59 |
Operating Income | -78.62 | -74.25 | -73.88 | -44.24 | -26.6 | -14.78 |
Interest Expense | -43.78 | -44.55 | -26.09 | -5.3 | -0.46 | -1.25 |
Interest & Investment Income | 1.4 | 1.4 | 2.4 | 1.84 | 0.31 | 0 |
Currency Exchange Gain (Loss) | -0.35 | -0.35 | -1.96 | -0.41 | -0.9 | -0.23 |
Pretax Income | -121.35 | -117.75 | -99.53 | -48.11 | -27.65 | -16.25 |
Income Tax Expense | - | - | - | - | 0.01 | 0 |
Net Income | -121.35 | -117.75 | -99.53 | -48.11 | -27.65 | -16.25 |
Net Income to Common | -121.35 | -117.75 | -99.53 | -48.11 | -27.65 | -16.25 |
Shares Outstanding (Basic) | 304 | 296 | 282 | 234 | 138 | 105 |
Shares Outstanding (Diluted) | 304 | 328 | 309 | 234 | 138 | 105 |
Shares Change (YoY) | 3.41% | 6.11% | 32.25% | 70.00% | 30.64% | 44.58% |
EPS (Basic) | -0.40 | -0.40 | -0.35 | -0.21 | -0.20 | -0.15 |
EPS (Diluted) | -0.40 | -0.40 | -0.35 | -0.21 | -0.20 | -0.15 |
Free Cash Flow | -107.28 | -112 | -107.29 | -36.92 | -18.62 | -13.14 |
Free Cash Flow Per Share | -0.35 | -0.34 | -0.35 | -0.16 | -0.14 | -0.13 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -117.66% | -167.72% | -91.32% | -89.78% | -46.22% | -32.99% |
Profit Margin | -181.61% | -265.97% | -123.02% | -97.63% | -48.06% | -36.28% |
Free Cash Flow Margin | -160.56% | -252.98% | -132.62% | -74.91% | -32.35% | -29.32% |
EBITDA | -77.83 | -73.47 | -73.59 | -44.22 | -26.58 | -14.77 |
EBITDA Margin | -116.48% | -165.94% | -90.96% | -89.75% | -46.20% | -32.96% |
D&A For EBITDA | 0.79 | 0.79 | 0.29 | 0.01 | 0.01 | 0.01 |
EBIT | -78.62 | -74.25 | -73.88 | -44.24 | -26.6 | -14.78 |
EBIT Margin | -117.66% | -167.72% | -91.32% | -89.78% | -46.22% | -32.99% |
Revenue as Reported | 66.82 | 44.27 | 80.9 | 49.28 | 57.54 | 44.81 |